Table 1:
Ts+4 vs T0 | Ts vs T0 | T4 vs T0 (Outgrown) | |||||||
---|---|---|---|---|---|---|---|---|---|
P value | Difference | q value | P value | Difference | q value | P value | Difference | q value | |
REG1A | 0.00000 | 1.649 | 0.000 | 0.0479 | 0.4157 | >0.99 | 0.945 | 0.014 | >0.99 |
IL-17A | 0.00000 | 3.879 | 0.000 | 0.00008 | 3.042 | 0.004 | 0.0623 | 0.814 | >0.99 |
CCL20 | 0.00004 | 3.888 | 0.002 | 0.01238 | 2.399 | 0.145 | 0.1227 | 0.960 | >0.99 |
IL-17C | 0.00006 | 4.648 | 0.002 | 0.21497 | 1.028 | 0.963 | 0.1153 | 0.682 | >0.99 |
IL8 | 0.00017 | 2.809 | 0.004 | 0.00001 | 3.498 | 0.001 | 0.0220 | 0.913 | 0.839 |
CXCL9 | 0.00193 | 1.450 | 0.021 | 0.53305 | 0.172 | 0.963 | 0.8391 | −0.059 | >0.99 |
IL10 | 0.00152 | 1.664 | 0.021 | 0.18411 | 0.376 | 0.950 | 0.5412 | 0.175 | >0.99 |
IL2 | 0.00183 | 2.271 | 0.021 | 0.00064 | 1.722 | 0.020 | 0.3822 | 0.126 | >0.99 |
IL6 | 0.00161 | 1.779 | 0.021 | 0.03533 | 1.198 | 0.289 | 0.0063 | 1.588 | 0.611 |
OSM | 0.00223 | 1.769 | 0.021 | 0.52136 | 0.331 | 0.963 | 0.8642 | −0.062 | >0.99 |
LIF | 0.00295 | 0.614 | 0.025 | 0.01899 | 0.191 | 0.177 | 0.1598 | 0.394 | >0.99 |
CCL25 | 0.00672 | 0.740 | 0.048 | 0.26773 | 0.254 | 0.963 | 0.9124 | −0.023 | >0.99 |
TNF | 0.00673 | 0.767 | 0.048 | 0.00721 | 0.729 | 0.120 | 0.9850 | 0.014 | >0.99 |
HGF | 0.00761 | 0.591 | 0.050 | 0.44960 | 0.134 | 0.963 | 0.2414 | −0.131 | >0.99 |
CCL4 | 0.00982 | 1.152 | 0.056 | 0.00773 | 1.299 | 0.120 | 0.7342 | 0.094 | >0.99 |
TGF-a | 0.00981 | 1.359 | 0.056 | 0.16102 | 0.450 | 0.950 | 0.9260 | −0.023 | >0.99 |
CCL3 | 0.02001 | 0.923 | 0.108 | 0.01488 | 1.028 | 0.155 | 0.5454 | 0.150 | >0.99 |
CXCL1 | 0.03006 | 0.729 | 0.152 | 0.01185 | 0.781 | 0.145 | 0.6001 | −0.161 | >0.99 |
MCP-1 | 0.04146 | 1.061 | 0.198 | 0.00479 | 1.358 | 0.112 | 0.2082 | 0.382 | >0.99 |
Difference = normalized protein units (Log2 scale). Significant values bolded. T0 = baseline, Ts = Time of symptoms, Ts+4 = 4 hours after symptoms. In asymptomatic (outgrown) challenges, a single post-challenge sample was obtained 4 hours after challenge (T4).